Who is sponsoring NCT06176183?

NCT06176183 is sponsored by Vilnius University.

What drugs are being tested in NCT06176183?

Interventions in NCT06176183: Arthroscopic meniscus repair.

What condition does NCT06176183 study?

NCT06176183 studies Meniscus Tear Caused by a Traumatic Event, Fibrin Clot Augmentation, Meniscal Repair.

Is NCT06176183 still recruiting?

NCT06176183 is currently recruiting now. Last updated 28 August 2025.

Last reviewed 2025-08-28 · How we verify

NCT06176183

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Comparative Prospective Study of the Arthroscopic Meniscal Repair Methods

Recruiting now NA Last updated 28 August 2025

What this trial tests

NA trial testing Arthroscopic meniscus repair in Meniscus Tear Caused by a Traumatic Event in 100 participants. Currently enrolling.

Timeline

26 May 2021

Primary endpoint
26 September 2025

26 December 2026

Quick facts

Lead sponsor	Vilnius University
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	100
Start date	26 May 2021
Primary completion	26 September 2025
Estimated completion	26 December 2026
Sites	2 locations across Lithuania

Drugs / interventions tested

Arthroscopic meniscus repair

Conditions studied

Meniscus Tear Caused by a Traumatic Event — all drugs for Meniscus Tear Caused by a Traumatic Event →
Fibrin Clot Augmentation — all drugs for Fibrin Clot Augmentation →
Meniscal Repair — all drugs for Meniscal Repair →

Sponsor

Vilnius University

Who can join

Adults 0 to 19, any sex, with Meniscus Tear Caused by a Traumatic Event or Fibrin Clot Augmentation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Performing arthroscopic meniscus repair following a traumatic meniscus tear as an alternative to a meniscectomy is now an acceptable choice. Preserving meniscus tissues is crucial due to the significant role they play as an essential part of the knee joint. It is essential to comprehend the additional tools that can impact the recovery of the meniscus after suturing. Patients have been randomly assigned into two groups using the computer "www.randomiser.org," and the treatment outcomes were compared after one year. One group of patients has received a standard meniscus suturing technique, whereas another group has experienced the meniscus suturing treatment with an additional fibrin clot approach. Data pertaining to demographics, clinical characteristics, radiological findings, and survey responses have been carefully collected prospectively.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Outcomes reported in trials of children and adolescent knee injuries : a systematic review.
Liew I, Low WX, Ikram A, McDonnell S, et al · · 2025 · cited 1× · PMID 40836653 · DOI 10.1302/2633-1462.68.bjo-2025-0005.r1
The Use of Fibrin Clot During Meniscus Repair in Young Patients Reduces Clinical Symptom Rates at 12-Month Follow-Up: A Pilot Randomized Controlled Trial.
Martinkėnienė VB, Austys D, Brazaitis A, Makulavičius A, et al · · 2025 · PMID 41011007 · DOI 10.3390/medicina61091616

Verify or expand the search:

Other Vilnius University trials

Trials by the same sponsor.

NCT06966752 — Comparison of Continuous Positive Airway Pressure (CPAP) and Non-Invasive Positive Pressure Ventilation (NIPPV) in Prete · NA · recruiting
NCT07024901 — The Effects of the Somatic Intervention 'Dance-Walk' on Body Awareness, Vitality, and Mental Health in Help-Seeking Adul · NA · completed
NCT06651411 — The Feasibility of Chatbot-based Stress Management Intervention STARS for Youth in Lithuania · NA · active not recruiting
NCT06475716 — Guided Internet-based Trauma-focused CBT Programme for Post-traumatic Stress Disorder 'Spring' · NA · not yet recruiting
NCT06502704 — Bile Acids and Microbiome in Early Colorectal Carcinogenesis · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06176183 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Vilnius University
Last refreshed: 28 August 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06176183.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing